Higher proportion of positive labeling of Syn, CD56, CgA, NSE, and TTF-1 in esophageal SCC implicate that they are valuably applied in differential diagnosis of the malignancy. The gene discussed is ENO2; the disease is esophageal squamous cell carcinoma.